GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Achiko AG (XSWX:ACHI) » Definitions » Return-on-Tangible-Equity

Achiko AG (XSWX:ACHI) Return-on-Tangible-Equity : 0.00% (As of Jun. 2022)


View and export this data going back to 2019. Start your Free Trial

What is Achiko AG Return-on-Tangible-Equity?

Return-on-Tangible-Equity is calculated as Net Income divided by its average total shareholder tangible equity. Total shareholder tangible equity equals to Total Stockholders Equity minus Intangible Assets. Achiko AG's annualized net income for the quarter that ended in Jun. 2022 was CHF-4.84 Mil. Achiko AG's average shareholder tangible equity for the quarter that ended in Jun. 2022 was CHF-5.99 Mil. Therefore, Achiko AG's annualized Return-on-Tangible-Equity for the quarter that ended in Jun. 2022 was N/A%.

The historical rank and industry rank for Achiko AG's Return-on-Tangible-Equity or its related term are showing as below:

XSWX:ACHI's Return-on-Tangible-Equity is not ranked *
in the Healthcare Providers & Services industry.
Industry Median: 10.62
* Ranked among companies with meaningful Return-on-Tangible-Equity only.

Achiko AG Return-on-Tangible-Equity Historical Data

The historical data trend for Achiko AG's Return-on-Tangible-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Achiko AG Return-on-Tangible-Equity Chart

Achiko AG Annual Data
Trend Dec18 Dec19 Dec20 Dec21
Return-on-Tangible-Equity
- - - -

Achiko AG Semi-Annual Data
Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22
Return-on-Tangible-Equity Get a 7-Day Free Trial - - - - -

Competitive Comparison of Achiko AG's Return-on-Tangible-Equity

For the Health Information Services subindustry, Achiko AG's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Achiko AG's Return-on-Tangible-Equity Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Achiko AG's Return-on-Tangible-Equity distribution charts can be found below:

* The bar in red indicates where Achiko AG's Return-on-Tangible-Equity falls into.



Achiko AG Return-on-Tangible-Equity Calculation

Achiko AG's annualized Return-on-Tangible-Equity for the fiscal year that ended in Dec. 2021 is calculated as

Return-on-Tangible-Equity=Net Income/( (Total Tangible Equity+Total Tangible Equity)/ count )
(A: Dec. 2021 )  (A: Dec. 2020 )(A: Dec. 2021 )
=Net Income/( (Total Stockholders Equity - Intangible Assets+Total Stockholders Equity - Intangible Assets )/ count )
(A: Dec. 2021 )  (A: Dec. 2020 )(A: Dec. 2021 )
=-8.586/( (-3.6+-4.629 )/ 2 )
=-8.586/-4.1145
=N/A %

Achiko AG's annualized Return-on-Tangible-Equity for the quarter that ended in Jun. 2022 is calculated as

Return-on-Tangible-Equity=Net Income/( (Total Tangible Equity+Total Tangible Equity)/ count )
(Q: Jun. 2022 )  (Q: Dec. 2021 )(Q: Jun. 2022 )
=Net Income/( (Total Stockholders Equity - Intangible Assets+Total Stockholders Equity - Intangible Assets)/ count )
(Q: Jun. 2022 )  (Q: Dec. 2021 )(Q: Jun. 2022 )
=-4.844/( (-4.629+-7.345)/ 2 )
=-4.844/-5.987
=N/A %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is two times the semi-annual (Jun. 2022) net income data. Return-on-Tangible-Equity is displayed in the 10-year financial page.


Achiko AG  (XSWX:ACHI) Return-on-Tangible-Equity Explanation

Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.


Be Aware

Net Income is used.

Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.


Achiko AG Return-on-Tangible-Equity Related Terms

Thank you for viewing the detailed overview of Achiko AG's Return-on-Tangible-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


Achiko AG (XSWX:ACHI) Business Description

Traded in Other Exchanges
N/A
Address
Tessinerplatz 7, Zurich, CHE, CH-8002
Achiko AG is developing disruptive diagnostic solutions that put people first. The company product is a rapid, reliable Covid-19 test with a companion app offering a user-friendly digital health passport. Achiko creates and develops aptamer-based diagnostics through its biotechnology division, AptameX, and companion health apps via its digital mobile health technology division, Teman Sehat. The AptameX DNA aptamer tests can be rapidly chemically synthesized, are cost-effective, and have wide potential across multiple disease diagnostics. Leveraging AptameX and Teman Sehat, Achiko aims to deliver fast, accurate, and affordable diagnostic testing for a range of pathogenic diseases and therapeutic indications in the rapidly evolving healthcare diagnostics field.

Achiko AG (XSWX:ACHI) Headlines

No Headlines